Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | LIMK1 | P53667 | 6/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 2/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.37 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13525448 | 0.86 | LIMK1 (0.43) | LIMK1SMN1; SMN2NPC1RAB9APIM1 | |
| SCHEMBL20635997 | 0.83 | LIMK1 (0.46) | CYP1A2CYP2A6LIMK1SMN1; SMN2NPC1 | |
| SCHEMBL10031393 | 0.82 | NPC1 (0.46) | CYP1A2CYP2A6SMN1; SMN2NPC1RAB9A | |
| SCHEMBL18470317 | 0.81 | LIMK1 (0.47) | LIMK1SMN1; SMN2PIM1PIM2PIM3 | |
| SCHEMBL18470287 | 0.79 | LMNA (0.42) | LIMK1PIM1PIM2PIM3 | |
| SCHEMBL1687688 | 0.79 | NPC1 (0.43) | CYP1A2CYP2A6SMN1; SMN2NPC1RAB9A | |
| SCHEMBL14942991 | 0.78 | CYP2A6 (0.46) | CYP1A2CYP2A6LIMK1SMN1; SMN2NPC1 | |
| SCHEMBL16978711 | 0.78 | RAB9A (0.44) | CYP1A2CYP2A6SMN1; SMN2NPC1RAB9A | |
| SCHEMBL19912100 | 0.78 | CYP1A2 (0.44) | CYP1A2CYP2A6LIMK1PIM1PIM2 | |
| SCHEMBL19912096 | 0.78 | CYP1A2 (0.41) | CYP1A2CYP2A6LIMK1PIM1PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9029840-B2 | Organic nanofiber structure based on self-assembled organogel, organic nanofiber transistor using the same, and method of manufacturing the organic nanofiber transistor | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-12 | — | — | US | disclosed |
| US-20130069040-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2013-03-21 | — | — | US | disclosed |
| US-8362464-B2 | Organic nanofiber structure based on self-assembled organogel, organic nanofiber transistor using the same, and method of manufacturing the organic nanofiber transistor | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-01-29 | — | — | US | disclosed |
| US-20100006824-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130069040-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | GAP43, NOTCH4, OGA | CYP1A2 2249/4885CYP2A6 3156/4885LIMK1 1232/4885 |
| US-20100006824-A1 | ORGANIC NANOFIBER STRUCTURE BASED ON SELF-ASSEMBLED ORGANOGEL, ORGANIC NANOFIBER TRANSISTOR USING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC NANOFIBER TRANSISTOR | GAP43, NOTCH4, OGA | CYP1A2 2249/4885CYP2A6 3156/4885LIMK1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.